Uridine-13C9
Uridine-13C9 (β-Uridine-13C9) is a 13C9-labeled form of Uridine. Uridine (β-Uridine) is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring (or more specifically, aribofuranose) via a β-N1-glycosidic bond[1].
Product Specifications
Product Name Alternative
β-Uridine-13C9
UNSPSC
12352005
Target
Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/Analog
Type
Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/uridine-13c9.html
Purity
99.00
Solubility
10 mM in DMSO
Smiles
O=[13C]1[13CH]=[13CH]N([13C@@H]2O[13C@H]([13CH2]O)[13C@@H](O)[13C@H]2O)[13C](N1)=O
Molecular Formula
13C9H12N2O6
Molecular Weight
253.14
References & Citations
[1]Sokoloski JA, et al., Effects of uridine on the growth and differentiation of HL-60 leukemia cells. Leuk Res. 1991;15 (11) :1051-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse BNP (Brain Natriuretic Peptide) ELISA Kit